Related Experiment Videos
MADIT-II: clinical implications
Arthur J Moss1, James Daubert, Wojciech Zareba
1Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. heartajm@heart.rochester.edu
Cardiac Electrophysiology Review
|November 20, 2002
Abstract:
The MADIT-II trial showed that in patients with a prior myocardial infarction and ejection fraction
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Low magnetic fields stimulate cardiac mitochondrial bioenergetics with a bell-shaped response: Possibly via a radical pair mechanism.
Computational and structural biotechnology journal·2025
Effect of Novel Programming on Inappropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Very Low Ejection Fraction (from A MADIT-RIT).
The American journal of cardiology·2022
Cost-effectiveness of the implantable cardioverter defibrillator.
Cardiac electrophysiology review·2004
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Cardiac electrophysiology review·2004
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).
Cardiac electrophysiology review·2004
Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
Cardiac electrophysiology review·2004
Possible delayed neuronal death after seemingly successful evacuation of traumatic acute subdural hematoma: Image report.
Surgical neurology international·2026
Large acute posttraumatic epidural hematoma centered beneath a cochlear implant: A case report.
Surgical neurology international·2026
Auditory Perceptions Associated With Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea.
Laryngoscope investigative otolaryngology·2026
Mesenchymal stem cells as cellular factories for targeted P2X7 blockade after traumatic brain injury.
Neuroprotection (Chichester, England)·2026
A third-generation, high-affinity biparatopic anti-tau antibody inhibits intracellular tau aggregation seeded by Alzheimer's brain extracts.
Alzheimer's research & therapy·2026